Table of Contents
1 Epigenetic Market Overview
1.1 Product Overview and Scope of Epigenetic
1.2 Epigenetic Segment by Type
1.2.1 Global Epigenetic Production and CAGR (%) Comparison by Type (2015-2027)
1.2.2 The Market Profile of Reagents
1.2.3 The Market Profile of Kits
1.2.4 The Market Profile of Instruments
1.2.5 The Market Profile of Enzymes
1.2.6 The Market Profile of Services
1.3 Global Epigenetic Segment by Application
1.3.1 Epigenetic Consumption (Sales) Comparison by Application (2015-2027)
1.3.2 The Market Profile of Academic & Research Institutes
1.3.3 The Market Profile of Pharmaceutical Companies
1.3.4 The Market Profile of Biotechnology Companies
1.3.5 The Market Profile of Contract Research Organizations
1.4 Global Epigenetic Market by Region (2015-2027)
1.4.1 Global Epigenetic Market Size (Value) and CAGR (%) Comparison by Region (2015-2027)
1.4.2 United States Epigenetic Market Status and Prospect (2015-2027)
1.4.3 Europe Epigenetic Market Status and Prospect (2015-2027)
1.4.3.1 Germany Epigenetic Market Status and Prospect (2015-2027)
1.4.3.2 UK Epigenetic Market Status and Prospect (2015-2027)
1.4.3.3 France Epigenetic Market Status and Prospect (2015-2027)
1.4.3.4 Italy Epigenetic Market Status and Prospect (2015-2027)
1.4.3.5 Spain Epigenetic Market Status and Prospect (2015-2027)
1.4.3.6 Russia Epigenetic Market Status and Prospect (2015-2027)
1.4.3.7 Poland Epigenetic Market Status and Prospect (2015-2027)
1.4.4 China Epigenetic Market Status and Prospect (2015-2027)
1.4.5 Japan Epigenetic Market Status and Prospect (2015-2027)
1.4.6 India Epigenetic Market Status and Prospect (2015-2027)
1.4.7 Southeast Asia Epigenetic Market Status and Prospect (2015-2027)
1.4.7.1 Malaysia Epigenetic Market Status and Prospect (2015-2027)
1.4.7.2 Singapore Epigenetic Market Status and Prospect (2015-2027)
1.4.7.3 Philippines Epigenetic Market Status and Prospect (2015-2027)
1.4.7.4 Indonesia Epigenetic Market Status and Prospect (2015-2027)
1.4.7.5 Thailand Epigenetic Market Status and Prospect (2015-2027)
1.4.7.6 Vietnam Epigenetic Market Status and Prospect (2015-2027)
1.4.8 Central and South America Epigenetic Market Status and Prospect (2015-2027)
1.4.8.1 Brazil Epigenetic Market Status and Prospect (2015-2027)
1.4.8.2 Mexico Epigenetic Market Status and Prospect (2015-2027)
1.4.8.3 Colombia Epigenetic Market Status and Prospect (2015-2027)
1.4.9 Middle East and Africa Epigenetic Market Status and Prospect (2015-2027)
1.4.9.1 Saudi Arabia Epigenetic Market Status and Prospect (2015-2027)
1.4.9.2 United Arab Emirates Epigenetic Market Status and Prospect (2015-2027)
1.4.9.3 Turkey Epigenetic Market Status and Prospect (2015-2027)
1.4.9.4 Egypt Epigenetic Market Status and Prospect (2015-2027)
1.4.9.5 South Africa Epigenetic Market Status and Prospect (2015-2027)
1.4.9.6 Nigeria Epigenetic Market Status and Prospect (2015-2027)
1.5 Global Market Size (Value) of Epigenetic (2015-2027)
1.5.1 Global Epigenetic Revenue Status and Outlook (2015-2027)
1.5.2 Global Epigenetic Production Status and Outlook (2015-2027)
2 Global Epigenetic Market Landscape by Player
2.1 Global Epigenetic Production and Share by Player (2015-2020)
2.2 Global Epigenetic Revenue and Market Share by Player (2015-2020)
2.3 Global Epigenetic Average Price by Player (2015-2020)
2.4 Epigenetic Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Epigenetic Market Competitive Situation and Trends
2.5.1 Epigenetic Market Concentration Rate
2.5.2 Epigenetic Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 QIAGEN N.V.
3.1.1 QIAGEN N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Epigenetic Product Profiles, Application and Specification
3.1.3 QIAGEN N.V. Epigenetic Market Performance (2015-2020)
3.1.4 QIAGEN N.V. Business Overview
3.2 Oncolys Biopharma Inc.
3.2.1 Oncolys Biopharma Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Epigenetic Product Profiles, Application and Specification
3.2.3 Oncolys Biopharma Inc. Epigenetic Market Performance (2015-2020)
3.2.4 Oncolys Biopharma Inc. Business Overview
3.3 Eisai Co. Ltd.
3.3.1 Eisai Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Epigenetic Product Profiles, Application and Specification
3.3.3 Eisai Co. Ltd. Epigenetic Market Performance (2015-2020)
3.3.4 Eisai Co. Ltd. Business Overview
3.4 Thermo Fisher Scientific, Inc.
3.4.1 Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Epigenetic Product Profiles, Application and Specification
3.4.3 Thermo Fisher Scientific, Inc. Epigenetic Market Performance (2015-2020)
3.4.4 Thermo Fisher Scientific, Inc. Business Overview
3.5 Illumina
3.5.1 Illumina Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Epigenetic Product Profiles, Application and Specification
3.5.3 Illumina Epigenetic Market Performance (2015-2020)
3.5.4 Illumina Business Overview
3.6 Novartis International AG
3.6.1 Novartis International AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Epigenetic Product Profiles, Application and Specification
3.6.3 Novartis International AG Epigenetic Market Performance (2015-2020)
3.6.4 Novartis International AG Business Overview
3.7 Active Motif.
3.7.1 Active Motif. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Epigenetic Product Profiles, Application and Specification
3.7.3 Active Motif. Epigenetic Market Performance (2015-2020)
3.7.4 Active Motif. Business Overview
3.8 Diagenode, Inc.
3.8.1 Diagenode, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Epigenetic Product Profiles, Application and Specification
3.8.3 Diagenode, Inc. Epigenetic Market Performance (2015-2020)
3.8.4 Diagenode, Inc. Business Overview
3.9 New England Biolabs, Inc.
3.9.1 New England Biolabs, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Epigenetic Product Profiles, Application and Specification
3.9.3 New England Biolabs, Inc. Epigenetic Market Performance (2015-2020)
3.9.4 New England Biolabs, Inc. Business Overview
3.10 Epizyme Inc.
3.10.1 Epizyme Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Epigenetic Product Profiles, Application and Specification
3.10.3 Epizyme Inc. Epigenetic Market Performance (2015-2020)
3.10.4 Epizyme Inc. Business Overview
3.11 Valirx plc.
3.11.1 Valirx plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Epigenetic Product Profiles, Application and Specification
3.11.3 Valirx plc. Epigenetic Market Performance (2015-2020)
3.11.4 Valirx plc. Business Overview
3.12 Syndax Pharmaceuticals, Inc.
3.12.1 Syndax Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Epigenetic Product Profiles, Application and Specification
3.12.3 Syndax Pharmaceuticals, Inc. Epigenetic Market Performance (2015-2020)
3.12.4 Syndax Pharmaceuticals, Inc. Business Overview
3.13 Domainex
3.13.1 Domainex Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Epigenetic Product Profiles, Application and Specification
3.13.3 Domainex Epigenetic Market Performance (2015-2020)
3.13.4 Domainex Business Overview
3.14 Zymo Research Corporation
3.14.1 Zymo Research Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Epigenetic Product Profiles, Application and Specification
3.14.3 Zymo Research Corporation Epigenetic Market Performance (2015-2020)
3.14.4 Zymo Research Corporation Business Overview
3.15 Merck & Co.
3.15.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Epigenetic Product Profiles, Application and Specification
3.15.3 Merck & Co. Epigenetic Market Performance (2015-2020)
3.15.4 Merck & Co. Business Overview
3.16 Chroma Therapeutics Ltd.
3.16.1 Chroma Therapeutics Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Epigenetic Product Profiles, Application and Specification
3.16.3 Chroma Therapeutics Ltd. Epigenetic Market Performance (2015-2020)
3.16.4 Chroma Therapeutics Ltd. Business Overview
3.17 Abcam Plc.
3.17.1 Abcam Plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Epigenetic Product Profiles, Application and Specification
3.17.3 Abcam Plc. Epigenetic Market Performance (2015-2020)
3.17.4 Abcam Plc. Business Overview
3.18 CellCentric Ltd.
3.18.1 CellCentric Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Epigenetic Product Profiles, Application and Specification
3.18.3 CellCentric Ltd. Epigenetic Market Performance (2015-2020)
3.18.4 CellCentric Ltd. Business Overview
4 Global Epigenetic Production, Revenue (Value), Price Trend by Type
4.1 Global Epigenetic Production and Market Share by Type (2015-2020)
4.2 Global Epigenetic Revenue and Market Share by Type (2015-2020)
4.3 Global Epigenetic Price by Type (2015-2020)
4.4 Global Epigenetic Production Growth Rate by Type (2015-2020)
4.4.1 Global Epigenetic Production Growth Rate of Reagents (2015-2020)
4.4.2 Global Epigenetic Production Growth Rate of Kits (2015-2020)
4.4.3 Global Epigenetic Production Growth Rate of Instruments (2015-2020)
4.4.4 Global Epigenetic Production Growth Rate of Enzymes (2015-2020)
4.4.5 Global Epigenetic Production Growth Rate of Services (2015-2020)
5 Global Epigenetic Market Analysis by Application
5.1 Global Epigenetic Consumption and Market Share by Application (2015-2020)
5.2 Global Epigenetic Consumption Growth Rate by Application (2015-2020)
5.2.1 Global Epigenetic Consumption Growth Rate of Academic & Research Institutes (2015-2020)
5.2.2 Global Epigenetic Consumption Growth Rate of Pharmaceutical Companies (2015-2020)
5.2.3 Global Epigenetic Consumption Growth Rate of Biotechnology Companies (2015-2020)
5.2.4 Global Epigenetic Consumption Growth Rate of Contract Research Organizations (2015-2020)
6 Global Epigenetic Production, Consumption, Export, Import by Region (2015-2020)
6.1 Global Epigenetic Consumption by Region (2015-2020)
6.2 United States Epigenetic Production, Consumption, Export, Import (2015-2020)
6.3 Europe Epigenetic Production, Consumption, Export, Import (2015-2020)
6.4 China Epigenetic Production, Consumption, Export, Import (2015-2020)
6.5 Japan Epigenetic Production, Consumption, Export, Import (2015-2020)
6.6 India Epigenetic Production, Consumption, Export, Import (2015-2020)
6.7 Southeast Asia Epigenetic Production, Consumption, Export, Import (2015-2020)
6.8 Central and South America Epigenetic Production, Consumption, Export, Import (2015-2020)
6.9 Middle East and Africa Epigenetic Production, Consumption, Export, Import (2015-2020)
7 Global Epigenetic Production, Revenue (Value) by Region (2015-2020)
7.1 Global Epigenetic Production and Market Share by Region (2015-2020)
7.2 Global Epigenetic Revenue (Value) and Market Share by Region (2015-2020)
7.3 Global Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.4 United States Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.5 Europe Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.6 China Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.7 Japan Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.8 India Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.9 Southeast Asia Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.10 Central and South America Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
7.11 Middle East and Africa Epigenetic Production, Revenue, Price and Gross Margin (2015-2020)
8 Epigenetic Manufacturing Analysis
8.1 Epigenetic Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Epigenetic
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Epigenetic Industrial Chain Analysis
9.2 Raw Materials Sources of Epigenetic Major Players in 2019
9.3 Downstream Buyers
10 Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Epigenetic
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 Global Epigenetic Market Forecast (2020-2027)
11.1 Global Epigenetic Production, Revenue Forecast (2020-2027)
11.1.1 Global Epigenetic Production and Growth Rate Forecast (2020-2027)
11.1.2 Global Epigenetic Revenue and Growth Rate Forecast (2020-2027)
11.1.3 Global Epigenetic Price and Trend Forecast (2020-2027)
11.2 Global Epigenetic Production, Consumption, Export and Import Forecast by Region (2020-2027)
11.2.1 United States Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.2 Europe Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.3 China Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.4 Japan Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.5 India Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.6 Southeast Asia Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.7 Central and South America Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.2.8 Middle East and Africa Epigenetic Production, Consumption, Export and Import Forecast (2020-2027)
11.3 Global Epigenetic Production, Revenue and Price Forecast by Type (2020-2027)
11.4 Global Epigenetic Consumption Forecast by Application (2020-2027)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology
13.2 Research Data Source